Abstract
Pharmaceutical industry marketers are confronted with specific ethical issues linked to the tension between the economic interest being pursued and the health mission of this sector. Indeed this dual mission could be problematic for them when the two objectives contradict each other. We use the concept of moral dissonance to examine how marketers in the pharmaceutical industry perceive the profit/health tension inherent in their sector and how they deal with it. Based on narratives of 18 marketers working in the pharmaceutical sector, our qualitative study identifies ethical conflicts of varying intensity that generate differing degrees of moral dissonance among marketers. To cope with this moral dissonance, they use the following strategies: (1) minimize the sensitivity of their activity; (2) invoke the benefits to patients; and (3) avoid behaviors that conflict with their values.
Similar content being viewed by others
Notes
Center for Disease Control and Prevention, cited by Le Monde, January 31st, 2020.
The phenomenon of justification has given rise to numerous studies drawing on similar concepts: moral rationalization, moral justification, self-justification…
Survey from TNS Sofres in 2018.
Laboratory in which a major health scandal (Mediator) took place in France.
The French National Drug Safety Agency.
Marketing authorization for drugs given by the health authorities in France (Autorisation de Mise sur le Marché).
References
Amos, E. A., & Weathington, B. L. (2008). An analysis of the relation between employee–organization value congruence and employee attitudes. The Journal of Psychology, 142(6), 615–632.
Ashforth, B. E., & Anand, V. (2003). The normalization of corruption in organizations. Research in Organizational Behavior, 25, 1–52.
Ashforth, B. E., Kreiner, G. E., Clark, M. A., & Fugate, M. (2007). Normalizing dirty work: Managerial tactics for countering occupational taint. Academy of Management Journal, 50(1), 149–174.
Bandura, A., Barbaranelli, C., Caprara, G. V., et al. (1996). Mechanisms of moral disengagement in the exercise of moral agency. Journal of Personality and Social Psychology, 71(2), 364–374.
Bao, Y., Vedina, R., Moodie, S., & Dolan, S. (2013). The relationship between value incongruence and individual and organizational well-being outcomes: An exploratory study among Catalan nurses. Journal of Advanced Nursing, 69(3), 631–641.
Barnet, T. (2001). Dimensions of moral intensity and ethical decision making: An empirical study. Journal of Applied Social Psychology, 31(5), 1038–1057.
Bazerman, M. H., & Banaji, M. R. (2004). The social psychology of ordinary ethical failures. Social Justice Research, 17(2), 111–115.
Bazerman, M. H., & Gino, F. (2012). Behavioral ethics: Toward a deeper understanding of moral judgment and dishonesty. Annual Review of Law and Social Science, 8, 85–104.
Brinkmann, J. (2002). Business and marketing ethics as professional ethics. Concepts, approaches and typologies. Journal of Business Ethics, 41(1–2), 159–177.
Chatzidakis, A., Hibbert, S., & Smith, A. (2007). Why people don’t cake their concerns about fair trade to the supermarket: The role of neutralisation. Journal of Business Ethics, 74(1), 89–100.
Cohn, J. (2016). The drug price controversy nobody notices. The Milbank Quarterly, 94(2), 260–263.
Cohn, A., Fehr, E., & Maréchal, M. A. (2014). Business culture and dishonesty in the banking industry. Nature, 516, 86–97.
Cooper, J. (2012). Cognitive dissonance theory. In P. A. M. Lange, A. W. Kruglanski, & E. T. Higgins (Eds.), Handbook of theories of social psychology (pp. 377–397). Thousand Oaks, CA: Sage.
Cooper, J., & Fazio, R. H. (1984). A new look at dissonance theory. Advances in Experimental Social Psychology, 17, 229–266.
Crié, D., & Chebat, J.-C. (2013). Health marketing: Toward an integrative perspective. Journal of Business Research, 66(1), 123–126.
Cromwell, P., & Birzer, M. L. (2012). The curious case of George: A case study of a career criminal. Criminal Justice Review, 37(4), 512–526.
Dion, M. (2012). Confits, dilemmes et crises éthiques sont-ils synonymes? [im]pertinences, (2), 73–85.
Divard, R. (2013). Comprendre les comportements non éthiques du consommateur : les apports de la théorie de la neutralisation. Management and Avenir, 60(2), 53–73.
Doblhofer, D. S., Hauser, A., Kuonath, A., Haas, K., Agthe, M., & Frey, D. (2019). Make the best out of the bad: Coping with value incongruence through displaying facades of conformity, positive reframing, and self-disclosure. European Journal of Work and Organizational Psychology, 28(5), 572–593.
Edwards, J. R., & Cable, D. M. (2009). The value of value congruence. Journal of Applied Psychology, 94(3), 654–677.
Festinger, L. (1957). A theory of cognitive dissonance. Palo Alto, CA: Stanford University Press.
Fournier, P., Muller, S., & Lomba, C. (2014). Les travailleurs du médicament : L’industrie pharmaceutique sous observation. Eres.
Gosling, P., Denizeau, M., & Oberlé, D. (2006). Denial of responsibility: A new mode of dissonance reduction. Journal of Personality and Social Psychology, 90(5), 722.
Gunia, B. C., Wang, L., Huang, L. I., Wang, J., & Murnighan, J. K. (2012). Contemplation and conversation: Subtle influences on moral decision making. Academy of Management Journal, 55(1), 13–33.
Heath, J. (2008). Business ethics and moral motivation: A criminological perspective. Journal of Business Ethics, 83(4), 595–614.
Hinojosa, A. S., Gardner, W. L., Walker, H. J., Cogliser, C., & Gullifor, D. (2017). A review of cognitive dissonance theory in management research: Opportunities for further development. Journal of Management, 43(1), 170–199.
Holland, R. W., Meertens, R. M., & Van Vugt, M. (2002). Dissonance on the road: Self-esteem as a moderator of internal and external self-justification strategies. Personality and Social Psychology Bulletin, 28(12), 1713–1724.
Huebner, J. M. (2014). Moral psychology and the intuition that pharmaceutical companies have a ‘special’ obligation to society. Journal of Business Ethics, 122(3), 501–510.
Jones, T. M. (1991). Ethical decision making by individuals in organizations: An issue-contingent model. Academy of Management Review, 16(2), 366–395.
Kammeyer-Mueller, J. D., Simon, L. S., & Rich, B. L. (2012). The psychic cost of doing wrong: Ethical conflict, divestiture socialization, and emotional exhaustion. Journal of Management, 38(3), 784–808.
Katamba, D., Marvin Nkiko, C., & Ademson, C. (2016). Managing stakeholders’ influence on embracing business code of conduct and ethics in a local pharmaceutical company: Case of Kampala Pharmaceutical Industries (KPI). Review of International Business and Strategy, 26(2), 261–290.
Kelman, H. C., & Baron, R. M. (1974). Moral and hedonic dissonance: A functional analysis of the relationship between discrepant action and attitude change. In S. Himmelfarb & A. H. Eagly (Eds.), Readings in attitude change (pp. 558–575). New York: Wiley.
Kohlberg, L. (1969). Stage and sequence: The cognitive-developmental approach to socialization. In D. A. Gosling (Ed.), Handbook of socialization theory and research (pp. 347–380). Chicago: Rand McNally.
Konovsky, M. A., & Jaster, F. (1989). “Blaming the victim” and other ways businessmen and women account for questionable behavior. Journal of Business Ethics, 8(5), 391–398.
Kristof-Brown, A. L., Zimmerman, R. D., & Johnson, E. C. (2005). Consequences of individuals’ fit at work: A meta-analysis of person–job, person–organization, person–group, and person–supervisor fit. Personnel Psychology, 58(2), 281–342.
Levillain, K. (2017). Les entreprises à mission: un modèle de gouvernance pour l’innovation. Paris, France: Vuibert.
Loe, T. W., Ferrell, L., & Mansfield, P. (2000). A review of empirical studies assessing ethical decision making in business. Journal of Business Ethics, 25(3), 185–204.
Lowell, J. (2011). Managers and moral dissonance: Self-justification as a big threat to ethical management? Journal of Business Ethics, 105(1), 17–25.
McGregor, S. L. (2008). Conceptualizing immoral and unethical consumption using neutralization theory. Family and Consumer Sciences Research Journal, 36(3), 261–276.
Maitland, I. (2002). Priceless goods: How should life-saving drugs be priced? Business Ethics Quarterly, 12(4), 451–480.
Maruna, S., & Copes, H. (2005). What have we learned from five decades of neutralization research? Crime and Justice, 32, 221–320.
McGrath, A. (2017). Dealing with dissonance: A review of cognitive dissonance reduction. Social and Personality Psychology Compass, 11(12), 1–17.
Messick, D. M., & Tenbrunsel, A. E. (1996). Codes of conduct: Behavioral research into business ethics. New York: Russell Sage Foundation.
Minor, W. W. (1981). Techniques of neutralization: A reconceptualization and empirical examination. Journal of Research in Crime and Delinquency, 18(2), 295–318.
Nussbaum, A. S. K. (2009). Ethical corporate social responsibility (CSR) and the pharmaceutical industry: A happy couple? Journal of Medical Marketing, 9(1), 67–76.
O’Fallon, M. J., & Butterfield, K. D. (2005). A review of the empirical ethical decision-making literature: 1996–2003. Journal of Business Ethics, 59(4), 375–413.
Odou, P., & Bonnin, G. (2014). Consumers’ neutralization strategies to counter normative pressure: The case of illegal downloading. Recherche et Applications en Marketing (English Edition), 29(1), 103–121.
Ravelli, Q. (2015). La Stratégie de la bactérie. Une enquête au cœur de l’industrie pharmaceutique. Le Seuil.
Ribeaud, D., & Eisner, M. (2010). Are moral disengagement, neutralization techniques, and self-serving cognitive distortions the same? Developing a unified scale of moral neutralization of aggression. International Journal of Conflict and Violence, 4(2), 298–315.
Rokeach, M. (1968). Beliefs, attitudes and values; a theory of organization and change. Journal of Social Issues, 24(1), 13–33.
Sachet-Milliat, A., Baïada-Hirèche, L., & Bourcier-Béquaert, B. (2017). The clear conscience of the controversial sector marketer: A neutralization theory approach. Recherche et Applications en Marketing (English Edition), 32(3), 28–48.
Sah, S., & Fugh-Berman, A. (2013). Physicians under the influence: Social psychology and industry marketing strategies. The Journal of Law, Medicine and Ethics, 41(3), 665–672.
Serviere-Munoz, L., & Mallin, M. L. (2013). How do unethical salespeople sleep at night? The role of neutralizations in the justification of unethical sales intentions. Journal of Personal Selling and Sales Management, 33(3), 289–306.
Shaw, B., & Whitney, P. (2016). Ethics and compliance in global pharmaceutical industry marketing and promotion: The role of the IFPMA and self-regulation. Pharmaceuticals Policy and Law, 18(1–4), 199–206.
Siegall, M., & McDonald, T. (2004). Person–organization value congruence, burnout and diversion of resources. Personnel Review, 33(3), 291–301.
Simon, L., Greenberg, J., & Brehm, J. (1995). Trivialization: the forgotten mode of dissonance reduction. Journal of Personality and Social Psychology, 68(2), 247–260.
Sims, R. R. (1992). Linking groupthink to unethical behavior in organizations. Journal of Business Ethics, 11(9), 651–662.
Steele, C. M. (1988). The psychology of self-affirmation: Sustaining the integrity of the self In: L. Berkowitz (Ed.). Advances in Experimental Social Psychology, 21, 261–302.
Steffen, J. E., Fassler, E. A., Reardon, K. J., & Egilman, D. S. (2018). Grave fraudulence in medical device research: A narrative review of the PIN seeding study for the Pinnacle hip system. Accountability in Research, 25(1), 37–66.
Strauss, A. L., Soulet, M.-H., Corbin, J. M., Emery, S., & Soulet, M.-H. (2004). Les fondements de la recherche qualitative: techniques et procédures de développement de la théorie enracinée. Academic Press/Saint-Paul.
Stremersch, S., & Van Dyck, W. (2009). Marketing of the life sciences: A new framework and research agenda for a nascent field. Journal of Marketing, 73(4), 4–30.
Sykes, G. M., & Matza, D. (1957). Techniques of neutralization: A theory of delinquency. American Sociological Review, 22(6), 664–670.
Tong, J., Wang, L., & Peng, K. (2015). From person–environment misfit to job burnout: Theoretical extensions. Journal of Managerial Psychology, 30(2), 169–182.
Travis, C., & Aronson, E. (2015). Mistakes were made (but not by me). Boston: Mariner Books.
Tsang, J.-A. (2002). Moral rationalization and the integration of situational factors and psychological processes in immoral behavior. Review of General Psychology, 6(1), 25–50.
Umphress, E. E., & Bingham, J. B. (2011). When employees do bad things for good reasons: Examining unethical pro-organizational behavior. Organization Science, 22, 621–640.
Vaidis, D., & Halimi-Falkowicz, S. (2007). La théorie de la dissonance cognitive : une théorie âgée d’un demi-siècle. Revue Electronique de Psychologie Sociale, 1, 9–18.
Valverde, J. (2012). Ethical challenges in the pharmaceutical industry. Pharmaceuticals, Policy and Law, 14(2/4), 123–127.
Van de Pol, P. K., & De Bakker, F. G. (2010). Direct-to-consumer advertising of pharmaceuticals as a matter of corporate social responsibility? Journal of Business Ethics, 94(2), 211–224.
Verschoor, C. C. (2011). Pharma ethics code isn’t working! Strategic Finance, 92(8), 17–20.
Vitell, S. J., & Grove, S. J. (1987). Marketing ethics and the techniques of neutralization. Journal of Business Ethics, 6(6), 433–438.
Voisin, D., & Fointiat, V. (2013). Reduction in cognitive dissonance according to normative standards in the induced compliance paradigm. Social Psychology, 44, 191–195.
Voisin, D., Rubens, L., N’gbala, A., & Gosling, P . (2013). Le choix du mode de réduction. In V. Fointiat, F. Girandola, & P. Gosling (Eds.), La dissonance cognitive (pp. 87–118). Paris: Armand Colin.
Acknowledgements
We would like to express our sincere thanks to the journal’s editor and reviewers for their thorough evaluation work and valuable advice that allowed us to advance our research significantly.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1: Interview Guide
I am conducting a scientific study on situations of ethical problems experienced by marketing professionals. In the interview, I would like you to tell me about problems or cases of conscience that you have encountered in the course of your duties/decision-making in marketing in France. What you say will remain strictly confidential. Neither your name nor the name of your company will be mentioned. This data will be used only in the context of publications in academic journals.
1. Could you briefly introduce yourself and say something about your job and career?
2. In your professional career (and specifically your role in marketing) have you ever been faced by a situation that has bothered your conscience? If this has happened on a number of occasions, focus on one or two that that most affected you. Can you tell me about it?
Follow-up on the description of the problem mentioned:
- Description of the problem
- Description of the organizational context (hierarchy, corporate culture, codes of ethics, legal department, etc.)
- Description of the external context (regulatory, economic, customer, sector, etc.)
- Protagonists: people or groups involved in the problem (legal/regulatory, general management, other departments, etc.)
- Focus on relations with the legal/regulatory department: description of the validation process, cases of projects rejected by the legal department
Follow-up on cases of conscience and how they were resolved:
- What did you do in this situation? And why?
- What decision(s) did you make?
- Can you explain why you chose to do this?
- Have you solicited other people (in the professional context? in the personal context?)
Follow-up on other situations giving rise to cases of conscience:
- Were there any operations where you thought you were going to cross a line?
- Were there any other decisions where you felt you were in an awkward position?
- Do you have examples of operations carried out by the competition that could have troubled your conscience if you had had to do them yourself?
3. And the fact of working in this sector, how was that initially?
Follow-up:
- Did you experience agreeing to take this job as a problem?
- Why did you agree to it?
4. Finally, are there any sectors in which you would not work? For what reasons?
Appendix 2
See Table 3.
Appendix 3
See Table 4.
Appendix 4
See Table 5.
Appendix 5
See Table 6.
Appendix 6
See Table 7.
Appendix 7
See Table 8.
Rights and permissions
About this article
Cite this article
Bourcier-Béquaert, B., Baïada-Hirèche, L. & Sachet-Milliat, A. Cure or Sell: How Do Pharmaceutical Industry Marketers Combine Their Dual Mission? An Approach Using Moral Dissonance. J Bus Ethics 175, 555–581 (2022). https://doi.org/10.1007/s10551-020-04657-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10551-020-04657-4